(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung cancer.
XTB analyst Kathleen Brooks commented: "The Bank of England is expected to cut interest rates, and the US NFP report for January is expected to report a sharp slowdown in job creation." Here is what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback